机器翻译,已经临床审核。

关节囊松解 资料

机器翻译,已经临床审核。

本方案涵盖基兰·希尔帕拉(Kieran Hirpara)医生在罗克汉普顿 Mater 私人医院进行的关节镜下关节囊松解术后的康复过程,包括住院期间及术后数周至数月的康复安排。请在首次物理治疗就诊时携带此页面或其 PDF 文件,以确保您的康复计划协调一致。您的物理治疗师将根据您肩关节的活动情况,按以下阶段个体化推进您的康复进程。

如果您在术后对伤口有任何疑虑,请联系诊室。拍摄伤口照片并通过电子邮件发送以供审查通常很有帮助。

预期情况

关节囊松解术是针对僵硬肩(冻结肩)的手术,这将彻底改变您的康复方式。大多数肩部手术旨在修复某些结构,如肌腱或撕裂的韧带,早期康复的重点是保护这些修复部位,因此您需要佩戴悬吊带,并将活动范围限制在特定限度内。而本手术则恰恰相反。没有任何缝合部位需要保护。外科医生在您麻醉状态下松解了关节内紧张且瘢痕化的关节囊内衬,并将肩关节活动至全范围,因此手术的成果即为活动度。从您苏醒的那一刻起,康复的核心任务就是维持这种活动度,以防止肩关节再次僵硬。

这意味着没有保护期,也无需有所保留。您应立即开始活动肩关节,既包括主动活动,也包括利用健侧手臂进行被动推动,并且每天多次在各个方向上持续增加活动范围。

您的锻炼涉及三种类型的活动,您的医疗团队将标明适用于您的类型:

  • 被动活动 指肩关节完全放松,由健侧手臂、木棍或滑轮承担所有动作。
  • 主动辅助活动 指您利用健侧手臂或辅助工具提供部分帮助,自行活动手臂。
  • 主动活动 指您依靠自身肌肉力量活动手臂,无需任何辅助。

为何不使用吊带

关节囊松解术后无需使用吊带保护修复组织,且保持肩部静止反而不利于康复。若任由其休息,松解后的肩部会再次变得僵硬。再僵硬化是该手术效果令人失望的主要原因,而通过早期且频繁的活动可很大程度上预防这一情况。

因此,与修复术不同,您无需在吊带中睡眠,也无需保持手臂静止,且没有任何动作是禁忌的。从术后第一天起,即鼓励您自由使用手臂,并在各个方向上努力扩大活动范围,包括向外旋转手臂。仅提供一个简单的吊带,用于短期舒适以及外出时防止手臂受到碰撞;请尽可能少地使用吊带,切勿因吊带而诱使您保持肩部静止。

要点

  • 保持活动。 从一开始就使用手臂进行日常活动,如洗漱、穿衣和进食。活动可维持手术中获得的关节活动度。
  • 在各个方向上努力增加活动范围。 拉伸至出现明显不适感,而非剧烈疼痛,并在每个平面上将肩部活动至极限,包括手臂外旋。术后无需遵循“切勿超过此处”的限制。
  • 少量多次拉伸。 每天多次进行简短的家庭拉伸练习,优于单次长时间拉伸。两次拉伸之间会出现关节再次僵硬,因此频率至关重要。
  • 控制疼痛以便能够活动。 在进行锻炼和物理治疗预约前服用止痛药。良好的疼痛控制是进行拉伸的前提。许多人发现拉伸前热敷、拉伸后冰敷有帮助。
  • 频繁进行物理治疗。 前六周内每周至少进行两次物理治疗。首次就诊时请携带本页内容。
  • 六周内禁止驾驶。 此规定适用于所有肩部手术,尽管您可能很快就能脱离悬吊带;您的外科医生通常会在六周复查时批准您恢复驾驶。

手术时常向关节内注射类固醇,以减轻炎症并降低再次僵硬的风险。

住院期间——您的首次锻炼

物理治疗师将在医院为您进行评估,并在您出院前开始指导您进行以下锻炼。这些练习有助于保持手、肘和肩部的活动,并立即开始促进肩关节活动度的恢复。请在锻炼前服用止痛药,以便能够自由活动。请按照医疗团队的指示进行锻炼,并在家中继续进行。

您的门诊康复

关节囊松解术后,康复进程与肌腱修复手术相反:无需保护,因此所有努力都集中于维持活动度。术后最初几周内,肩关节最易再次僵硬,因此物理治疗需立即开始,保持高频次,并持续数月,直至您的活动范围稳定。以下阶段遵循该手术已发表的康复方案模式(来源列于文末)。周数范围仅为典型参考,而非固定标准:您的物理治疗师将根据您肩关节的活动进展进行调整,而非依据日历。

概览:

  • 第一阶段 — 早期康复: 大约前两周
  • 第二阶段 — 维持和恢复活动范围: 第2至6周
  • 第三阶段 — 强化训练: 第6至12周
  • 第四阶段 — 恢复全面活动: 第12周起

大约三周后,肩关节高度以下的活动通常变得更加舒适,大部分活动范围得以恢复,尽管手臂在过头活动时通常仍感不适。大约三个月后,大多数人发现症状已基本缓解,且改善通常持续六至九个月,有时长达一年。

第一阶段——早期康复(第0–2周)

前两周的目标很简单:不要丧失手术中获得的关节活动度。 您需在家继续进行医院的锻炼,每天多次,并增加将肩关节向各个方向拉伸至极限的拉伸动作。良好的疼痛控制是实现这一目标的关键,因此请在锻炼和物理治疗前按时服用止痛药,并在拉伸前使用热敷、拉伸后使用冰敷(如果对您有帮助)。在日常生活中,如洗漱、穿衣和进食时,正常使用患肢。将每次拉伸进行到有明显不适感为止,而非剧烈疼痛,并请记住,无需刻意回避任何方向的活动。

进入下一阶段的条件是…… 您能够自信且独立地每天多次完成家庭锻炼计划,疼痛控制良好,足以将关节拉伸至目标活动范围,并且能够维持肩关节在手术中已获得的关节活动度。

第二阶段——保持并恢复活动范围(第2–6周)

本阶段继续进行频繁的理疗和每日多次的家庭拉伸训练,以确保手术中获得的活动度不丢失,并持续增加活动范围。您的锻炼从辅助运动逐渐过渡到在所有方向上主动活动手臂,理疗师可能会增加手法关节松动术以提供帮助。在各个平面(包括外旋)上,将活动范围推至其最大极限。在日常活动中正常使用手臂进行轻度活动。

进入下一阶段的条件是…… 手术中获得的活动度得以维持或仍在改善,肩关节高度以下的活动感到舒适,且疼痛已减轻到足以开始轻柔的抗阻训练。

第三阶段——强化训练(第6–12周)

随着关节活动度趋于稳定,重点转向重建肩部力量。本阶段需继续进行每日拉伸,因为强化训练绝不能以牺牲来之不易的活动度为代价。抗阻训练从轻柔开始,使用弹力带和轻重量针对肩袖肌群和肩胛骨周围肌肉进行锻炼,采用低负荷、高重复次数的方案。日常活动应基本恢复正常,在物理治疗师的指导下,较轻的休闲活动通常也可在此阶段恢复。

进入下一阶段的条件是…… 您在各个方向上均能实现完全或接近完全的无痛活动,且能够完成强化训练而不会引发疼痛加剧或任何活动度丧失。

第四阶段——恢复全面活动(第12周起)

最终阶段是逐步恢复较重的工作、 overhead 任务及体育运动。正式康复通常总共持续三至四个月,且肩关节在此之后仍会持续改善:大多数人会继续在六至九个月内,有时长达一年,不断获得舒适感和信心。建议坚持简短的拉伸练习,直到你的关节活动度无需正式锻炼也能自行维持。进展仍以你的主观感受为指导,因此如果僵硬或疼痛开始复发,应对措施是减轻负荷并恢复活动度,而非让肩关节休息。

恢复活动

大多数人在4至6周内即可恢复正常日常活动及多种类型的工作,因为此处的康复关键在于维持关节活动度,而非等待组织愈合。随着力量逐渐恢复,较重体力劳动及 overhead(过顶)运动将在随后的数周至数月内逐步恢复。如果在任何阶段肩部再次出现僵硬,应将其视为加强拉伸的信号,并及时就诊物理治疗师,而非休息。

您的练习

术后康复阶段

上述门诊康复阶段改编自已发表的关节镜关节囊松解术康复方案,恢复里程碑亦源自相同文献。周数范围为典型情况而非固定值,您的持续康复由物理治疗师根据肩部功能恢复情况,结合本诊所要求,进行个体化指导。本页面内容应与本诊所的一般术后恢复建议配合使用:详见术后疼痛管理伤口护理。关于手术本身及其治疗的疾病,请参阅关节囊松解术冻结肩


Evidence & references

This is the clinical evidence summary written for health professionals. It is technical, and it lists the research this page was built from. You do not need to read it to understand your treatment or to make a decision about it.

Topic scope: Both (A) non-operative staged management of primary/secondary adhesive capsulitis (freezing -> frozen -> thawing), including physiotherapy, intra-articular steroid and hydrodilatation; and (B) post-operative rehabilitation after arthroscopic capsular release (ACR).

Defining principle of surgical rehab here (the inversion): Unlike virtually every other shoulder operation -- where a repair (cuff, labrum, pec major, instability) must be protected with a sling and ROM is restricted to avoid disrupting healing tissue -- frozen-shoulder release rehab is the OPPOSITE: the goal is to prevent re-formation of the capsular contracture. So the protocol is immediate, aggressive ROM, usually NO sling, passive + active ROM starting the same day or day 1, with stretching to the end of the freshly gained range. Delay or immobilisation is the enemy (re-stiffening), not the protector. This is the single most important point distinguishing this protocol from the others in this audit.


A. NON-OPERATIVE STAGED MANAGEMENT

Natural history / staging (consensus, weak evidence -- descriptive, no RCT)

Frozen shoulder is self-limiting in most but typically lasts 12-18 months across 3 clinical stages (Reeves' classic model; staging boundaries overlap and are not sharply separable in practice -- flagged as weak/consensus evidence; the original Reeves model was a single prospective cohort of 49 patients, not an RCT) [Brigham SOC; Chan 2017; Reeves 1975 via Willmore 2020]:

Stage Name Typical duration Clinical picture Management emphasis
1 Freezing (painful/inflammatory) 2-9 months Diffuse constant pain, worse at night; progressive ROM loss in a capsular pattern (ER > ABD > flexion > IR); loss of passive ER with arm at side is the hallmark Pain control; intra-articular steroid; gentle ROM within pain limits -- do NOT force end-range while highly inflamed
2 Frozen (adhesive/stiff) 4-12 months Pain subsides to dull ache; stiffness dominant; marked functional loss Restore motion: stretching, joint mobilisation grades III-IV, hydrodilatation; consider surgery if recalcitrant
3 Thawing 6-9 months (Brigham) Gradual spontaneous return of motion Progressive ROM + strengthening; PT 2-3x/week

(Stage durations from Brigham Standard of Care 2010 and Chan 2017: freezing 2-9 mo, frozen 4-12 mo, thawing 6-9 mo.)

Stepped non-operative interventions

  1. Education / "supervised neglect" + analgesia -- many resolve with reassurance, activity modification and analgesia alone (Codman; Hsu 2011 review). Weak (cohort/expert).
  2. Physiotherapy -- pendulum, PROM/AAROM/AROM, capsular stretching, joint mobilisation (grades I-II early for pain, III-IV later for tissue extensibility), scapular/posture work. Brigham: PT 1-2x/week in early stages (mainly HEP instruction), 2-3x/week in thawing. PT is best supported as an adjunct to mobilisation/injection/distension, not as a stand-alone cure (Itoi 2016 Current Concepts; Kelley/McClure/Leggin JOSPT 2009 guidance). Moderate; intensity/timing debated. Intensity caveat: end-range/high-intensity stretching is appropriate in the frozen/thawing phase but can be counter-productive in the acutely inflamed freezing phase -- match intensity to irritability (Kelley 2009).
  3. Intra-articular corticosteroid (glenohumeral) -- superior to placebo and to physiotherapy for short-term (up to 4-12 weeks) pain and function; benefit wanes after ~3 months. Strong for short term (multiple RCTs; Koh 2016 systematic review of 10 RCTs; Cochrane Buchbinder shoulder injection review). BESS pathway: GH steroid recommended for short-term symptom control; long-term (>3 mo) benefit not demonstrated (Rupani/Gwilym BESS 2025). Earlier injection (freezing phase) is the rationale -- steroid targets the inflammatory component.
  4. Hydrodilatation (distension arthrography) -- distends/ruptures the contracted capsule with saline +/- steroid +/- LA. A controlled, image-guided alternative to surgery. RCT/meta-analytic evidence is mixed: generally produces a transient functional/ROM gain, with no clear superiority over IA steroid alone in several network meta-analyses (Wu 2017 SR/MA of RCTs; Lin 2018 network MA). Some evidence hydrodilatation + steroid > steroid alone in refractory cases (Lee 2017 RCT). Low rate of needing later surgery after distension arthrogram (Nicholson 2020). Moderate; conflicting.

B. POST-OPERATIVE REHABILITATION (the "immediate aggressive ROM" protocols)

Surgery is reserved for cases recalcitrant to >=3-6 months of adequate non-operative care (Struyf 2024; Mullen 2025).

Arthroscopic capsular release (ACR)

  • Controlled, direct-vision release of the contracted capsule (rotator interval, CHL, anterior +/- inferior +/- 360 degree capsulotomy; care re axillary nerve inferiorly). Allows graded release with a low risk of iatrogenic fracture or cuff tear (Kanbe 2018, n=255; Jerosch 2001 360 degree release). Achieves reliable gains in final forward elevation and may shorten recovery (most improved by ~4 months -- McAllister/CORR Insights 2025; Saade 2023 MA favoured ACR for AFE). A gentle, controlled manipulation is often performed as part of the arthroscopic release to confirm the gained range.

Consensus POST-OP phased timeline (applies after arthroscopic capsular release)

The hallmark is immediate motion, no protective sling, same-day/day-1 ROM to hold the range just won in theatre.

Phase Window Sling ROM Active ROM Strengthening Notes
0 -- Immediate Day 0-1 (same day) NO sling (or sling only briefly for comfort/analgesia, discarded fast) Full passive ROM immediately; PT-assisted forward flexion + ER begun day 1; +/- continuous passive motion (CPM); pendulums; patient does HEP several times/day AAROM/AROM started day 1 alongside PROM (no protected period) -- Intra-articular steroid often injected at time of release to damp post-op inflammatory re-stiffening
1 -- Early Week 0-2 None Aggressive PROM/AAROM to maintain gained range; stretch into end-range daily; hold ER/ABD/flexion Active motion continued Light scapular/rotator-cuff activation as pain allows Pain control critical to allow the patient to move -- adequate analgesia / interscalene block / oral steroid taper
2 -- Strengthening Week 2-6 None Continue to full ROM Full AROM goal Rotator cuff + scapular strengthening begins ~week 2 (Kanbe protocol) Most back to normal daily activity / work by 4-6 weeks
3 -- Return to function ~6 weeks-3 months None Maintain full ROM Full Progressive strengthening to full Recurrence of stiffness is the main failure mode -> continued HEP emphasised

Representative published protocol (Kanbe 2018, J Orthop Surg Res, n=255, ACR): "passive, assisted-active and stooping (pendulum) exercises for forward flexion and external rotation commenced 1 day after surgery... after 2 weeks of passive exercise, patients began active exercise to strengthen the rotator cuff and scapular stabilisers... after 4-6 weeks patients returned to normal work without limitation." Many ACR series add an intra-articular steroid + controlled manipulation at the index procedure (Filip Struyf 2024; PMC5137660).

Post-surgical physiotherapy is universally agreed to be essential but is under-standardised -- there is no high-level RCT defining the optimal post-release regimen; protocols are consensus/expert and vary widely (Willmore 2020 Shoulder & Elbow, "Post-surgical physiotherapy in frozen shoulder: a review"). Weak/consensus.


KEY CONTROVERSIES

  1. Evidence base for arthroscopic release. ACR gives a controlled, direct-vision release with a low iatrogenic fracture/cuff-tear risk and reliable gains in final elevation. Systematic reviews show consistently acceptable results, though there is no definitive RCT defining the optimal technique (Saade 2023 MA; McAllister 2025). Weak/moderate evidence (large cohorts).
  2. Steroid timing. Strong short-term benefit (<12 wk) but no durable >3-month benefit; debate over injecting early (freezing/inflammatory phase) vs reserving for refractory cases (Koh 2016; Rupani/Gwilym BESS 2025; Lin 2018).
  3. Aggressive vs gentle physiotherapy. High-intensity end-range stretching helps in the frozen/thawing phases but may worsen pain and prolong the condition if applied to the acutely inflamed freezing phase -- "intensity should match irritability" (Kelley/McClure 2009; Itoi 2016). Post-operatively, by contrast, aggressive immediate ROM is mandatory to prevent re-stiffening.
  4. Hydrodilatation worth it? Transient benefit only and not clearly better than IA steroid alone in pooled RCT data (Wu 2017; Lin 2018), though some refractory-case RCT support (Lee 2017) and a low rate of needing later surgery (Nicholson 2020).
  5. Does anything change the natural history? No intervention is proven to shorten the overall 12-18 month course in the highest-quality reviews; most accelerate symptom relief rather than alter end-point (Rookmoneea 2010 JBJS Br; Hsu 2011). Strong (negative).

EVIDENCE STRENGTH FLAGS (summary)

  • STRONG (RCT / SR-MA): IA corticosteroid short-term benefit (Koh 2016 SR of 10 RCTs; Cochrane); hydrodilatation = transient, not superior to steroid (Wu 2017 SR-MA of RCTs; Lin 2018 network MA).
  • MODERATE: end-range/scapular mobilisation (Yang 2012 RCT); ACR clinical outcomes (large cohorts -- Kanbe 2018 n=255; Jerosch 2001).
  • WEAK / CONSENSUS ONLY: 3-stage natural-history model & stage durations (Reeves cohort, descriptive); the post-operative rehab protocol itself (no defining RCT; expert/consensus -- Willmore 2020); optimal ACR technique (published series are heterogeneous).

CITATIONS

RAG corpus (180,000+ Orthopaedic articles)

  • Guyver P, Bruce D, Rees J. Frozen shoulder -- a stiff problem that requires a flexible approach. Maturitas. 2014.
  • Kim J, Gahlot N, Park HB. Frozen shoulder: a narrative review of current treatment concepts and the underlying scientific evidence. Clinics in Shoulder and Elbow. 2025;28(4).
  • Hsu JE, Anakwenze OA, Warrender WJ, et al. Current review of adhesive capsulitis. J Shoulder Elbow Surg. 2011;20(3):502-514.
  • Koh KH. Corticosteroid injection for adhesive capsulitis in primary care: a systematic review of randomised clinical trials. Singapore Med J. 2016.
  • Rupani N, Gwilym SE. British Elbow and Shoulder Society patient care pathway: Frozen shoulder. Shoulder & Elbow. 2025;17(4).
  • Sheridan MA, Hannafin JA. Upper Extremity: Emphasis on Frozen Shoulder. Orthop Clin North Am. 2006.
  • Chan H, Pua P, How C. Physical therapy in the management of frozen shoulder. Singapore Med J. 2017.
  • Willmore EG, Millar NL, van der Windt D. Post-surgical physiotherapy in frozen shoulder: a review. Shoulder & Elbow. 2020;14(4).
  • Lamplot JD, Lillegraven O, Brophy RH. Outcomes from conservative treatment of shoulder idiopathic adhesive capsulitis... Orthop J Sports Med. 2018.
  • Itoi E, Arce G, Bain GI, et al. Shoulder Stiffness: Current Concepts and Concerns. Arthroscopy. 2016;32(7).
  • Kanbe K. Clinical outcome of arthroscopic capsular release for frozen shoulder: essential technical points in 255 patients. J Orthop Surg Res. 2018;13(1). (post-op protocol: day-1 ROM, 4-6 wk RTW)
  • Jerosch J. 360 degree arthroscopic capsular release in patients with adhesive capsulitis... Knee Surg Sports Traumatol Arthrosc. 2001;9(3).
  • McAllister NB. CORR Insights: Releasing forces in adhesive capsulitis... Clin Orthop Relat Res. 2025.
  • Saade F, van Rooij F, Saffarini M, et al. Management of shoulder stiffness following rotator cuff repair: a systematic review and meta-analysis. JSES Rev Rep Tech. 2023.
  • Wu W, Chang K, Han D, et al. Effectiveness of glenohumeral joint dilatation for treatment of frozen shoulder: a systematic review and meta-analysis of RCTs. Sci Rep. 2017. (SR-MA of RCTs)
  • Lin M, Hsiao M, Tu Y, et al. Comparative efficacy of intra-articular steroid injection and distension... a systematic review and network meta-analysis. Arch Phys Med Rehabil. 2018. (network MA)
  • Lee D, Yoon S, Lee MY, et al. Capsule-preserving hydrodilatation with corticosteroid vs corticosteroid alone in refractory adhesive capsulitis: a randomized controlled trial. Arch Phys Med Rehabil. 2017. (RCT)
  • Nicholson JA, Slader B, Martindale A, et al. Distension arthrogram in the treatment of adhesive capsulitis has a low rate of repeat intervention. Bone Joint J. 2020;102-B(5).
  • Uppal HS. Frozen shoulder: a systematic review of therapeutic options. World J Orthop. 2015.
  • Mullen JP, Hauer TM, Lau EN, et al. Adhesive capsulitis of the shoulder. Arthroscopy. 2025;41(7).
  • Yang J, Jan M, Chang C, et al. Effectiveness of the end-range mobilization and scapular mobilization approach... a randomized control trial. Manual Therapy. 2012. (RCT)
  • Rookmoneea M, et al. The effectiveness of interventions in the management of patients with primary frozen shoulder. J Bone Joint Surg Br. 2010;92-B(9).
  • Struyf F. Frozen Shoulder. 2024 (surgical indication & post-op steroid + controlled manipulation).

Published rehab protocols (URLs)

  • Brigham & Women's Hospital -- Standard of Care: Shoulder Adhesive Capsulitis (Dept of Rehabilitation Services, 2010): https://www.brighamandwomens.org/assets/BWH/patients-and-families/rehabilitation-services/pdfs/shoulder-adhesive-capsulitis.pdf (source for the 12-18 mo / 3-stage durations, capsular pattern, PT frequency 1-2x/wk early & 2-3x/wk thawing, mobilisation grades, steroid 4-6 wk short-term benefit).
  • BESS (British Elbow & Shoulder Society) Frozen Shoulder patient care pathway -- Rupani & Gwilym, Shoulder & Elbow 2025 (GH steroid short-term only, no >3 mo benefit).
  • Kanbe 2018 ACR open-access (post-op day-1 ROM protocol): https://pmc.ncbi.nlm.nih.gov/articles/PMC5857121/
  • ChoosePT / APTA patient guide to frozen shoulder (lay phased overview): https://www.choosept.com/guide/physical-therapy-guide-frozen-shoulder-adhesive-capsulitis